When the ongoing contrast media shortage first started impacting health systems, one group in Ohio pledged not to delay a single procedure in its cath labs.

The Society of Nuclear Medicine and Molecular Imaging has chosen its 2022 Image of the Year, and it’s one that is sure to interest anyone in the field of cardiac imaging.

Researchers examined the clinical impact of treating valvular AFib with dabigatran instead of warfarin. 

The 2022-2023 rankings include some familiar names at the top. Did your facility make the cut? 

When discussing the possibility of TAVR for a patient with COPD, it is crucial to consider the severity of their symptoms.  

The company will use the funds to follow up on what it learned from the REDUCE LAP-HF II clinical trial.

The study touts the benefits of targeted radionuclide alpha therapy for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who have not had success with other treatments.